| 2017 | 2018 | 2019 | |
| 胸部壁心エコー | 3840 | 3787 | 3749 |
| 経食道心エコー | 214 | 203 | 271 |
| 心筋シンチ | 330 | 415 | 371 |
| 冠動脈CT | 341 | 230 | 280 |
| 冠動脈造影検査 | 700 | 658 | 533 |
| 冠動脈形成術 | 225 | 210 | 247 |
| 末梢血管形成術 | 115 | 130 | 162 |
| アブレーション | 198 | 225 | 261 |
| 経カテーテル大動脈弁植込み術 | 18 | 38 | 38 |
| バルーン肺動脈形成術 | 11 | 9 | 8 |
| ペースメーカー | 89 | 73 | 76 |
| ICD | 27 | 21 | 24 |
| CRT | 11 | 12 | 10 |
| 心リハ実施件数 | 2883 | 3395 | 5228 |
| 2017 | 2018 | 2019 | |
| 総入院患者数 | 673 | 645 | 705 |
| 肺癌 | 315 | 270 | 288 |
| 胸部異常陰影精査 | 48 | 88 | 87 |
| 肺炎・胸膜炎 | 149 | 144 | 147 |
| 間質性肺炎 | 67 | 68 | 89 |
| 気管支喘息・COPD | 43 | 44 | 12 |
| その他 | 51 | 31 | 82 |
| 気管支鏡検査数（EBUS-GS,TBNA含む） | 251 | 263 | 293 |
| 2017 | 2018 | 2019 |
Arimoto T, Watanabe E, Kohno R, Shimeno K, Kikuchi K, Doi A, Inoue K, Nitta T, Nogami A, Abe H, Okumura K.
CImpact of a poor functional capacity on the clinical outcomes in patients with a pacemaker implantation -Results from the Japanese Heart Rhythm Society Registry. J Arrhythm. 2020 Dec 9;37(1):182-188.
Watanabe K, Narumi T, Watanabe T, Otaki Y, Takahashi T, Aono T, Goto J, Toshima T, Sugai T, Wanezaki M, Kutsuzawa D, Kato S, Tamura H, Nishiyama S, Takahashi H, Arimoto T, Shishido T, Watanabe M.
CThe association between microRNA-21 and hypertension-induced cardiac remodeling. PLoS One. 2020 Feb 10;15(2):e0226053.
Toshima T, Watanabe T, Narumi T, Otaki Y, Shishido T, Aono T, Goto J, Watanabe K, Sugai T, Takahashi T, Yokoyama M, Kinoshita D, Tamura H, Kato S, Nishiyama S, Arimoto T, Takahashi H, Miyamoto T, Sadahiro M, Watanabe M.
CTherapeutic inhibition of microRNA-34a ameliorates aortic valve calcification via modulation of Notch1-Runx2 signalling. Cardiovasc Res. 2020 Apr 1;116(5):983-994.
Suzuki N, Matsuki E, Araumi A, Ashitomi S, Watanabe S, Kudo K, Ichikawa K, Inoue S, Watanabe M, Ueno Y, Ishizawa K, Kayama T, Konta T.
CAssociation among chronic kidney disease, airflow limitation, and mortality in a community-based population: The Yamagata (Takahata) study. Sci Rep. 2020 Mar 27;10(1):5570.
Sakurada K, Konta T, Watanabe M, Ishizawa K, Ueno Y, Yamashita H, Kayama T.
CAssociations of Frequency of Laughter With Risk of All-Cause Mortality and Cardiovascular Disease Incidence in a General Population: Findings From the Yamagata Study. J Epidemiol. 2020 Apr 5;30(4):188-193.
Kinoshita D, Shishido T, Takahashi T, Yokoyama M, Sugai T, Watanabe K, Tamura H, Nishiyama S, Takahashi H, Arimoto T, Miyamoto T, Watanabe T, Kishida S, Kadomatsu K, Abe JI, Takeishi Y, Konta T, Kubota I, Watanabe M.
CGrowth Factor Midkine Aggravates Pulmonary Arterial Hypertension via Surface Nucleolin. Sci Rep. 2020 Jun 25;10(1):10345.
Watanabe K, Takahashi H, Watanabe T, Otaki Y, Kato S, Tamura H, Nishiyama S, Arimoto T, Shishido T, Watanabe M.
CEndovascular Revascularization Improves the Central Hemodynamics and Augmentation Index in Patients with Peripheral Artery Disease. Intern Med. 2020 Jan 1;59(1):37-44.
Sato K, Inoue S, Igarashi A, Tokairin Y, Yamauchi K, Kimura T, Nishiwaki M, Nemoto T, Nakano H, Sato M, Machida H, Yang S, Minegishi Y, Furuyama K, Watanabe M, Shibata Y.
CEffect of Iron Deficiency on a Murine Model of Smoke-induced Emphysema. Am J Respir Cell Mol Biol. 2020 May;62(5):588-597.
Otaki Y, Watanabe T, Konta T, Watanabe M, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Kasahara M, Shibagaki Y, Iseki K, Moriyama T, Kondo M, Watanabe T.
CImpact of calculated plasma volume status on all-cause and cardiovascular mortality: 4-year nationwide community-based prospective cohort study. PLoS One. 2020 Aug 20;15(8):e0237601.
Goto J, Otaki Y, Watanabe T, Kobayashi Y, Aono T, Watanabe K, Wanezaki M, Kutsuzawa D, Kato S, Tamura H, Nishiyama S, Arimoto T, Takahashi H, Shishido T, Watanabe M.
CHECT (Homologous to the E6-AP Carboxyl Terminus)-Type Ubiquitin E3 Ligase ITCH Attenuates Cardiac Hypertrophy by Suppressing the Wnt/β-Catenin Signaling Pathway. Hypertension. 2020 Dec;76(6):1868-1878.
Otaki Y, Watanabe T, Konta T, Tamura H, Kato S, Nishiyama S, Takahashi H, Arimoto T, Shishido T, Watanabe M.
CThe impact of kidney dysfunction categorized by urinary to serum creatinine ratio on clinical outcomes in patients with heart failure. Heart Vessels. 2020 Feb;35(2):187-196.
Machida H, Inoue S, Shibata Y, Kimura T, Sato K, Abe K, Murano H, Yang S, Nakano H, Sato M, Nemoto T, Sato C, Nishiwaki M, Yamauchi K, Igarashi A, Tokairin Y, Watanabe M.
CThymus and activation-regulated chemokine (TARC/CCL17) predicts decline of pulmonary function in patients with chronic obstructive pulmonary disease. Allergol Int. 2021 Jan;70(1):81-88.
Otaki Y, Watanabe T, Konta T, Watanabe M, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Kasahara M, Shibagaki Y, Iseki K, Moriyama T, Kondo M, Watanabe T.
CImpact of hyperuricemia on mortality related to aortic diseases: a 3.8-year nationwide community-based cohort study. Sci Rep. 2020 Aug 31;10(1):14281.
Igarashi A, Inoue S, Shibata Y, Nunomiya K, Ota T, Ishibashi Y, Murano H, Furuyam K, Yang S, Machida H, Nakano H, Sato K, Sato M, Nemoto T, Nishiwaki M, Yamauchi K, Suzuki J, Sadahiro M, Watanabe M.
CExamination of predictable factors of perioperative respiratory complications by preoperative forced oscillation technique parameters. EXCLI J. 2020 Dec 21;19:1610-1614.
Watanabe K, Watanabe T, Otaki Y, Shishido T, Murase T, Nakamura T, Kato S, Tamura H, Nishiyama S, Takahashi H, Arimoto T, Watanabe M.
CImpact of plasma xanthine oxidoreductase activity in patients with heart failure with preserved ejection fraction. ESC Heart Fail. 2020 Aug;7(4):1735-1743.
Sato M, Inoue S, Arao T, Igarashi A, Yamauchi K, Sato K, Nakano H, Watanabe M.
CUndifferentiated pleomorphic sarcoma in the anterior mediastinum with a rapidly progressive course: A case report. EXCLI J. 2020 Aug 17;19:1161-1165.